G/TBT/N/CAN/444
24 April 2015 
(15-2202)  Page: 1/2
Committee on Technical Barriers to Trade  Original: English/French
 
  NOTIFICATION 
The following notification is being circulated in accordance with Article 10.6 
 
1. Notifying Member: CANADA  
If applicable, name of local government involved (Article 3.2 and 7.2):  
2. Agency responsible: Department of Health 
Name and address (including telephon e and fax numbers, email and website 
addresses, if available) of agency or authority designated to handle comments 
regarding the notification shall be indicated if different from above : 
Canada's Notification Authority and Enquiry Point 
Foreign Affairs, Trade and Development Canada 
Technical Barriers and Regulations Division (TIB) 111 Sussex Drive, Ottawa, ON K1A 0G2 Canada 
Telephone: (343)203-4273 
Fax: (613)943-0346 E-mail: enquirypoint@international.gc.ca   
3. Notified under Article 2.9.2 [X], 2.10 .1 [ ], 5.6.2 [ ], 5.7.1 [ ], other:  
4. Products covered (HS or CCCN where applic able, otherwise national tariff heading. 
ICS numbers may be provided in addition, where applicable): Veterinary drugs 
(ICS: 11.220) 
5. Title, number of pages and language(s) of the notified document: Notice of intent to 
amend the Food and Drug Regulations (3 pages, available in English and French)  
6. Description of content: Health Canada intends to introduce proposed amendments to the 
Food and Drug Regulations  to encourage prudent use of antimicrobial drugs used in food-
producing animals, particularly drugs that are considered medically important. This effort 
is important to minimize the global emergence and spread of antimicrobial resistance 
(AMR), and conserve the effectiveness of avai lable antimicrobials. The proposed regulatory 
a m e n d m e n t s  a r e  p a r t  o f  t h e  G o v e r n m e n t  o f  C a n a d a ' s  A c t i o n  P l a n  o n  A n t i m i c r o b i a l  
Resistance (AMR) and Use in Canada (http://healthycanadians.gc.ca/publications/drugs-
products-medicaments-produits/antibiotic-resistance-antibiotique/action-plan-daction-
eng.php?_ga=1.244209345.579612151.1408475073), which builds on the Federal 
Framework for Action (http://www.healthycan adians.gc.ca/drugs-p roducts-medicaments-
produits/antibiotic-resistance-antibiotique/antimicrobial-framework-cadre-antimicrobiens-
eng.php) announced on 24 October 2014.  
The proposed regulatory amendments aim to address personal use importation 
of veterinary drugs and strengthen the contro l over the importation of veterinary active 
pharmaceutical ingredients (APIs). This will support efforts to minimize AMR risks from antimicrobial use in animals and will allow for effective international alignment on the 
regulation of veterinary drugs. 
7. Objective and rationale, including the nature of urgent problems where 
applicable: Protecting animal health, public health and food safety  G/TBT/N/CAN/444 
 
- 2 - 
 
  8. Relevant documents:  
• Canada Gazette , Part I, 18 April 2015, page 815-817 (available in English and 
French) 
• Health Canada News Release 17 April 2015: http://news.gc.ca/web/article-
en.do?mthd=index&crtr.page=1&nid=965249   
9. Proposed date of adoption: Not stated 
Proposed date of entry into force: Not stated   
10. Final date for comments: Not stated 
11. Texts available from: Nati onal enquiry point [X] or address, telephone and fax 
numbers and email and website addresses, if available, of other body: The electronic 
version of this notice of intent can be found: 
http://www.gazette.gc.c a/rp-pr/p1/2015/2015-04 -18/pdf/g1-14916.pdf  
http://www.gazette.gc .ca/rp-pr/p1/2015/201 5-04-18/html/notice -avis-eng.php#ne3   
http://www.gazette.gc .ca/rp-pr/p1/2015/201 5-04-18/html/notice -avis-fra.php#ne3